コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 His 212 is located at the fulcrum of these conformationa
2 His achievements included proving the occurrence of benz
3 His AFP level declined rapidly after resection, and comp
4 His article spurred theoretical development in epidemiol
5 His bilateral visual acuity was no light perception (NLP
6 His boosting the image of the scalpel wielder helped sha
7 His brother with low-to-moderate-affinity IgG1 and IgG3
8 His cancer remains in complete remission 3 years later w
9 His case was reviewed by several specialists to develop
10 His condition was complicated by pulmonary emboli and lo
11 His cure is attributed to leukemia treatment that includ
12 His current work focuses on nematode-bacterial interacti
13 His Eastern Cooperative Oncology Group performance statu
14 His examination was consistent with cerebellar and upper
15 His family noted word-finding difficulty, especially wit
16 His father had childhood type 1 diabetes in poor glycemi
17 His height was at the 25th percentile for chronological
18 His inferences were bold, because no close ethnographic
19 His influence on macrocyclic and supramolecular chemistr
20 His initial abdominal CT showed no signs of posstraumati
21 His interests (always primarily arboviruses but now also
22 His laboratory evaluation showed normal blood cell count
23 His markedly elevated inhibin B was unable to inhibit FS
24 His medical history included prostate cancer, hypertensi
25 His medical history was significant for hyperlipidemia a
26 His most recent electrocardiogram was profoundly changed
27 His mother had asthma, but there was no other family his
28 His mother has Sickle cell anaemia (Hb SS) and his fathe
29 His name will always be associated with the discovery of
30 His physician noted a mildly distended abdomen that was
31 His postoperative antibody profile was found to be subst
32 His previous treatment included orchiectomy, which revea
33 His professional life coincided with the early developme
34 His proposal for comparative semiotic analyses of how vi
35 His proposal to repeal and replace the Affordable Care A
36 His prostate-specific antigen (PSA) level was 7.1 ng/mL.
37 His PSA was monitored every 6 months and gradually incre
38 His research talent at du Pont earned him an appointment
39 His serum AFP level was elevated at 47 ng/mL.
40 His serum alphafetoprotein level normalised within 2 mon
41 His sister had a history of multiple visual abnormalitie
42 His social history was notable for a 20-pack-year smokin
43 His studies of the relationships between physical activi
44 His temperature was 38.1 degrees C, and physical examina
45 His theories, however, did not arise de novo, being stro
46 His three lines of chemotherapy left him with chronic pe
47 His visual acuity continued deteriorating.
48 His work on phagocytosis has continued to flourish, part
49 His(85) is a potential proton donor to reactive iron-oxo
50 His-143 and His-189 also increase the pKa of the pyridin
53 involves residues Asp-222, His-143, Thr-139, His-189, and structural waters, is located at the edge o
54 is network, which involves residues Asp-222, His-143, Thr-139, His-189, and structural waters, is loc
57 tability in vitro The effects of the Asp-302-His-305 salt bridge are thus complex and context-depende
58 ubstrate, and thus, a flexible loop (Glu-334-His-343) is essential in binding sucrose and beta(2-1)-l
60 surface including the side chains of Arg 6, His 11 and Lys 32 as potentially important in the FS50 N
64 used on OleTJE active site residues Phe(79), His(85), and Arg(245) to interrogate their roles in subs
67 possess an N-terminal extension containing a His- and Asp/Glu-rich hypervariable region followed by a
68 tion and immobilization of SrtA containing a His-tag from the fermentation supernatant onto a nickel-
70 nated by two His ligands, one of which has a His-brace in which the His-1 terminal amine group also c
73 ed to bind tetradentate siderophores using a His and a Tyr side chain to complete the Fe(III) coordin
74 Thermoplasma acidophilum, by introducing a (His)6-tag within a loop in the alpha subunit of the comp
75 sts, 18 [Ac-Arg-Arg-(pI)DPhe-Tic-NH2], 1 [Ac-His-Arg-(pI)DPhe-Tic-NH2], and 41 [Ac-Arg-Arg-(pI)DPhe-D
77 s-19, indicating that the solvent-accessible His-27 facilitates proton conduction of the channel by i
79 C has an active site composed of Cys-129 and His-269, and the surrounding active site cleft is hydrop
81 ilent, but a double mutant with His(273) and His(274) exchanged for asparagines exhibits a much less
82 rogen-bonded salt bridge between Asp-302 and His-305 is particularly interesting as Asp-302 is the si
83 analyses revealed that residues His-333 and His-350 in the cytoplasmic C-terminal domain were requir
86 ve that atypical residues of Hb, His(58) and His(89) of alphaHb, coordinate to the heme iron, which i
89 iochemical studies indicated that Tyr 97 and His 138 are key residues for catalytic reaction and that
90 cluding human thrombin, PDGF-BB, Avidin, and His-tagged recombinant protein, were studied, and the re
91 cytoplasmic extensions that contain Cys- and His-rich high affinity metal binding domains, which may
92 uting diaminopropionic acid (Dap), DDap, and His at the Asn position yielded potent MC4R ligands, whi
93 tructures complexed with imidazole, HOL, and His with NAD(+) provided in-depth insights into the enzy
96 residues Asp-45 and Asp-49 in the second and His-153 and Asp-157 in the fifth transmembrane segments
97 n helix 1, which contains the N terminus and His-3, and has been associated with cognate metal bindin
98 the aromatic amino acids Phe, Tyr, Trp, and His within peptide medicinal chemistry are showcased her
99 anar (including aromatic (Phe, Trp, Tyr, and His)/amide (Asn and Gln)/Guanidine (Arg)) side-chains an
103 HyaA-R193L variant to disrupt a proposed Arg-His cation-pi interaction in the secondary coordination
104 ent the structure of the ZRANB3 HNH (His-Asn-His) endonuclease domain and provide a detailed analysis
106 on to the membrane-bound Asp-His-His and Asp-His-His-associated (DHH/DHHA1) domain-containing phospho
108 w that in addition to the membrane-bound Asp-His-His and Asp-His-His-associated (DHH/DHHA1) domain-co
109 overcomes the reliance on the conserved Asp-His hydrogen bonding interaction, leading to a catalytic
111 iers, glutamic acid, aspartyl-histidine (Asp-His), cycloserine (cSer), and arginine, which provided a
113 wn as DHHC3), a Golgi apparatus-specific Asp-His-His-Cys (DHHC) zinc finger protein; (ii) a GODZ domi
117 ry time, Wenckebach cycle length, and atrial-His (AH) interval were measured before and after every r
118 e binds in a 6-coordinate complex with axial His and Cys ligands, the latter provided by a heme-regul
119 cytochrome c contains three hemes with axial His/Met ligation, whereas heme 3 exhibits the His/Cys co
120 pha5 helix and the pi-pi interaction between His(57) and Phe(189) In addition, the insertion mutant a
126 ture, including loss of iron coordination by His-238 apparently from an altered conformation of the c
128 We also find that the pKa of the catalytic His substantially increases in CmpI, indicating that thi
129 revealed the position of the characteristic His-Cys catalytic dyad (His(99) and Cys(136)), and an As
130 omogeneity by anion exchange chromatography, His-Trap affinity chromatography and gel filtration.
133 nsensus C:G base pairs H-bond with conserved His or Arg residues in ZnF8, ZnF9, and ZnF11, and the co
134 ent polarity and length (i.e. Ala, Arg, Cys, His, Glu, and Leu) on transporter stability and function
135 des containing nucleophilic sidechains (Cys, His, and Lys) and selected proteins (bovine and human he
137 s build up H2N-Pro-Gly-Ala-CONHL and H2N-Cys-His-Asp-CONHL (where L = organic struts) amino acid sequ
139 L-cholesterol, and as tools to study the Cys-His-rich domain-dependent sorting the PCSK9-LDLR complex
140 tudies have shown that PCSK9 lacking its Cys/His-rich domain can still promote LDLR internalization,
141 GhCHR contains two DC1 and three PHD Cys/His-rich domains, suggesting that GhCHR encodes a zinc-f
142 t is the first time that histidine-cysteine (His-Cys) and histidine-lysine (His-Lys) in addition to h
143 were harnessed as a powerful means to direct His-tagged fluorophores to distinct locations within the
145 oup, result in autophosphorylation of a DosS His residue, followed by phosphotransfer to an Asp resid
146 f the characteristic His-Cys catalytic dyad (His(99) and Cys(136)), and an Asp (Asp(134)) in the pote
148 e the ionization properties of lipid-exposed His, Lys, and Arg side chains in lipid bilayer membranes
149 trains have an unusual Phe 43 cavity-filling His 375 residue, which increases the propensity of Env t
150 esults suggest pKa values of less than 3 for His(12) and about 3-5 for His(14) in DOPC membranes.
154 Here, we used rhDNase, which only forms His-His covalent dimers after light treatment to determi
156 The specific activity of TopA expressed from His-tagged fusion construct in the chromosome is inverse
157 earrangement, promoting a ligand switch from His-209 to His-212 and triggering heme release to HemO.
158 riants containing amino acids Ala, Asn, Gln, His, Ile, and Lys at positions equivalent to 782 and/or
159 oken down mainly into two fragments from Glp-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt (LHRHa) to Trp-Se
160 seven enantiomer pairs d/l-Ala, -Asp, -Glu, -His, -Leu, -Ser, -Val and the three achiral amino acids
161 ine-diglycolic acid-DPhe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt), showing excellent tumor localizing effica
162 ymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 ((68)Ga-RM2) is a synthetic bombesin rec
163 ymethyl-piperidine-d-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 ((68)Ga-RM2) is a synthetic bombesin rec
164 e also observe that atypical residues of Hb, His(58) and His(89) of alphaHb, coordinate to the heme i
165 nd purified as an N-terminal hexahistidine ((His)6) tagged fusion containing one zinc ion per DapE mo
166 Zn very tightly only in the presence of high His and makes Zn bioavailable through His catabolism.
169 work-guided GWAS signal was for a histidine (His)-related trait in a region containing two genes: a c
171 His-Lys) in addition to histidine-histidine (His-His) cross-links were discovered in monoclonal antib
172 , and archaebacteria synthesise L-histidine (His) in a similar, multistep pathway that is absent in m
173 ct photochemical oxidation of the histidine (His) residue by (1)O2 is a major degradation pathway for
175 resulting in an arginine (Arg) to histidine (His) substitution in its encoded protein, NIPA (Nuclear
176 BM2 contains a second titratable histidine, His-27, in the tetrameric transmembrane domain that form
177 we present the structure of the ZRANB3 HNH (His-Asn-His) endonuclease domain and provide a detailed
179 several amino acid substitutions (including His, Phe, Pro, Trp, and Tyr) support an enhanced viabili
180 o obtain 3D peptide crystals and incorporate His-tag-based cargoes and may have potential use in drug
182 ramework (MOF) based on the tripeptide Gly-l-His-Gly (GHG) for the enantioselective separation of met
184 es prepared from metallochelation liposomes, His-tagged antigen rOspA from Borrelia burgdorferi, and
185 ine-cysteine (His-Cys) and histidine-lysine (His-Lys) in addition to histidine-histidine (His-His) cr
186 a fully conserved histidine residue in MraY (His-289 in BsMraY), which has been experimentally confir
187 but not in ECs transfected with pcDNA3.1-myc-His-Phe(138)-CaM, the lysoPC-induced TRPC6-CaM dissociat
188 Cs transiently transfected with pcDNA3.1-myc-His-Phe(99)-CaM, but not in ECs transfected with pcDNA3.
190 ation states of Asp-219 and Glu-447, and not His, strongly determined the pH-dependent transport perm
191 nts led to the conclusion that the charge of His 212 in RasGRP1 alters signaling activity and plasma
192 tates/composition (different combinations of His protonation states or different metal-ligating ligan
195 ber of protein chains and thus the number of His ligands), and (4) ligand composition by evaluating t
196 , we demonstrate that the photoreactivity of His is determined by both solvent accessibility and stru
198 intriguing possibility that the presence of His 375 in the circulating strain where the RV144 trial
200 ogous expression and partial purification of His-tagged CesA5 from Physcomitrella patens Immunoblot a
202 the factors that influence the reactivity of His in proteins, especially the intrinsic factors are li
210 an uncharacteristic five-coordinate base-off/His-off conformation, whereby the dimethylbenzimidazole
212 of a set of 25 analogues featuring Ala(1) or His(1) and a variety of aromatic side chains at the aza-
213 ectively) but not conserved in E. coli OtsA (His, Leu, and Asp, respectively), providing a rationale
214 rnative techniques such as multisite pacing, His bundle pacing, and endocardial left ventricular paci
216 Incorporation of specific binding peptide (His Pro Gln: HPQ) gives M13 bacteriophage high selectivi
218 thesized analogue, Ac-Arg-Ala-[d-Cys-Arg-Phe-His-Pen]-COOH (19), displayed subnanomolar affinity towa
219 anomolar agonist potency at the mMC4R, c[Pro-His-DPhe-Arg-Trp-Asn-Ala-Phe-DPro] and c[Pro-His-DPhe-Ar
220 His-DPhe-Arg-Trp-Asn-Ala-Phe-DPro] and c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro], and may be further devel
222 of mda-7/IL-24 or treatment with recombinant His-MDA-7 protein resulted in downregulation of miR-221
223 hat is formed by three icosahedrally related His residues in the N termini of the C subunit at the qu
225 o-face pi-pi-stacking with the LRH-1 residue His-390, as well as by a novel polar interaction mediate
227 ns with the conserved Q-binding-site residue His-38 and that conformational changes between these bin
228 utagenesis we show that a histidine residue (His-347) downstream of S6 reduces inhibition by divalent
229 ficant rearrangements of side chain residues His(57), Phe(189), Phe(191), and Phe(336); it also distu
230 analysis suggests that pre-S1 loop residues His-402 and Tyr-403 play an important role in regulating
231 Further analyses revealed that residues His-333 and His-350 in the cytoplasmic C-terminal domain
233 His residue with the side chain of a second His residue to create a T-shaped arrangement of nitrogen
237 es in CmpI, indicating that this active site His is the source of the proton required in the reductio
239 dinative interaction of oligohistidine-tags (His-tags) with metal-organic framework nanoparticles (MO
241 -rich fragment of rSp0032 and the C-terminal His-rich fragment show unique transformations by either
242 amino group and side chain of the N-terminal His residue with the side chain of a second His residue
245 etrad protonates with higher pKa values than His-19, indicating that the solvent-accessible His-27 fa
247 g binding and activity assays, we found that His 336 of UBA5, previously not reported to be part of t
249 plasma membrane recruitment, indicating that His 212 is a pH sensor that alters the balance between t
252 vation time relative to the QRS onset at the His bundle and successful ablation sites than the LV sum
253 is/Met ligation, whereas heme 3 exhibits the His/Cys coordination typical for TsdA active sites.
254 early activation was always recorded in the His bundle region, regardless of the location of the VA
255 talytically inactive Phe substitution in the His-Asp catalytic dyad of CurJ-DH to elucidate substrate
256 such as .OH at the non-heme iron site in the His-cluster region formed by the active site conversion.
261 munoprecipitation assay, substitution of the His or Cys heme ligands in Rev-erbbeta was accompanied b
265 mational change is necessary to relocate the His-289 residue, such that the translocase reaction can
266 us envelope, (15)N NMR spectra show that the His-27 tetrad protonates with higher pKa values than His
267 ly acidic pH values in the endosome when the His(37) residues in the middle of the transmembrane doma
268 s, one of which has a His-brace in which the His-1 terminal amine group also coordinates to a copper.
272 he Met-Gln-Trp sequence of the canonical Thr-His-Trp (THW) loop known to interact with the methyl-acc
277 t with our model, the mutation of Cys-431 to His in the THW loop of human PRMT9 shifts its product sp
279 and additionally a hydrogen bond (G1324S) to His(1322) across the beta2-beta3 hairpin in the GPIbalph
281 2 arylated histidines containing tripeptides His(2-Ar)-Trp-His(2-Ar) exhibit potent antifungal activi
282 G)), tRNA(Pro(UGG)), tRNA(Pro(CGG)) and tRNA(His(GUG)) for Um, and tRNA(Pro(GGG)) for Am. tRNA(Ser(UG
283 ses, and its members include eukaryotic tRNA(His) guanylyltransferase (Thg1), as well as Thg1-like pr
284 iTLP2 catalyzes a mitochondria-specific tRNA(His) maturation reaction, which is distinct from the tRN
285 on reaction, which is distinct from the tRNA(His) maturation reaction typically catalyzed by Thg1 enz
286 tidines containing tripeptides His(2-Ar)-Trp-His(2-Ar) exhibit potent antifungal activity against Cry
287 most potent peptide 12f [His(2-biphenyl)-Trp-His(2-biphenyl)] displayed high in vitro activity agains
289 hat it contains a Cu atom coordinated by two His and one Cys in a trigonal plane, with an axial H2O a
290 center contains a Cu(II) coordinated by two His ligands, one of which has a His-brace in which the H
291 tion factor has been modified to include two His residues at designed i and i+4 positions of its N-te
292 Removing either the Cys residue or the two His residues lowers the Cu-peptide affinity, but site sp
295 selected for the external binding of various His-tagged synthetic peptides and recombinant or chemica
297 mportant role in ligand recognition, whereas His-89 is essential for signal transduction to the kinas
300 remarkably silent, but a double mutant with His(273) and His(274) exchanged for asparagines exhibits
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。